What benefit can be derived from treating normocholesterolemic patients with coronary artery disease?

This publication has 16 references indexed in Scilit:

• Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
  The Lancet, 1994
• Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
  Circulation, 1994
• Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
  Circulation, 1993
• Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.
  Heart, 1993
• Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.
  Circulation, 1992
• Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with “desirable” total cholesterol levels
  The American Journal of Cardiology, 1991
• Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia
  American Heart Journal, 1991
• Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death.
  Circulation, 1989
• Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.
  Journal of Clinical Investigation, 1984
• The Relationship Between Plasma and Tissue Lipids in Human Atherosclerosis
  Published by Elsevier ,1974